Magnesium Sulfate Injection, Solution
Product Images NDC 0404-9903

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Magnesium Sulfate (NDC 0404-9903). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1.jpg (Image1)

This text provides a list of substances that can be harmful or dangerous in certain concentrations. The list includes alcohol, alkali carbonates and bicarbonates, alkali hydroxides, arsenates, barium, calcium, clindamycin phosphate, heavy metals, hydrocortisone sodium succinate, phosphates, polymyxin B sulfate, procaine hydrochloride, salicylates, strontium, and tartrates. These substances may pose a risk to human health or the environment and should be handled with care.*

FDA Label Image

Image2.jpg (Image2)

This text describes a plastic syringe with the NDC number 0409-1754-10 and brand name Ansyr. The syringe has a total concentration of 5g/10mL, with 50% concentration and 4 mEq/mL. The syringe is not described as usable for any specific purpose.*

FDA Label Image

Image3.jpg (Image3)

This is a list of 12 scientific articles documenting the potential adverse effects of prolonged maternal magnesium administration, particularly in the context of tocolysis for premature labor, on the bone metabolism and mineralization of neonates and their risk of skeletal demineralization and fractures. The studies cover a period of research from 1980 to 2010 and explore the impact of magnesium sulfate treatment on the calcium metabolism, bone mineral content, and metaphyses of newborns.*

FDA Label Image

Image4.jpg (Image4)

FDA Label Image

Label1.jpg (Label1)

This is information about a medication labeled as "50% MAGNESIUM SULFATE". It is available as an injection in a single-dose syringe of 10ml size, and is intended for intravenous or intramuscular use. It is advised to dilute before intravenous use, using an aseptic technique. The medication should be kept out of the reach of children and stored between 20-25°C (68-77°F) with excursions permitted between 15-30°C (59-86°F). For more details about the product, one should refer to the manufacturer's insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.